Gut Microbiota and Short-Chain Fatty Acids: Key Factors in Pediatric Obesity and Therapeutic Targets
Authors:
- Alin Constantin PînzariuAlin Constantin Pînzariu
- Sebastian Marian LeonteSebastian Marian Leonte
- Alexandra Gabriela TrofinATAlexandra Gabriela Trofin
- Laura Mihaela TrandafirLTLaura Mihaela Trandafir
- Mihaela MoscaluMMMihaela Moscalu
- Lorena Mihaela ManoleLMLorena Mihaela Manole
- Roxana MoscaluRMRoxana Moscalu
- Cristina Iuliana LazărCLCristina Iuliana Lazăr
- Luminita Georgeta ConfederatLCLuminita Georgeta Confederat
- Vlad Ionuț VlăsceanuVVVlad Ionuț Vlăsceanu
- Radu Petru SoroceanuRSRadu Petru Soroceanu
- Daniel Vasile TimofteDaniel Vasile Timofte
Open Access
- 27 November 2025
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (23) , 11503
Abstract
Obesity in the pediatric population has become a public health problem with an increasing prevalence in recent years. The gut microbiota and its metabolites, especially short-chain fatty acids (SCFAs), play vital roles in the development of pediatric obesity. This manuscript aims to highlight the link between the gut microbiota and obesity by examining microbial imbalances, such as altered Firmicutes/Bacteroidetes ratios and altered SCFA production, especially butyrate, propionate, and acetate. Advances in genomic technologies, such as 16S rRNA sequencing, have enabled personalized treatments and detailed profiling of microbial diversity. This review includes not only preclinical studies but also clinical trials of interventions, such as probiotics, synbiotics, prebiotics, and butyrate supplements. These may modify the microbiota and SCFA levels to reduce obesity and related conditions, such as metabolic syndrome and precocious puberty. Future research should focus on using advanced genomic sequencing techniques to develop new therapeutic strategies, as well as on creating a complex predictive algorithm for assessing metabolic risk in pediatric patients with obesity, an innovation that can be extended to other metabolic conditions.Keywords
This publication has 231 references indexed in Scilit:
- Gut microbiome-based interventions for the management of obesity in children and adolescents aged up to 19 yearsCochrane Database of Systematic Reviews, 2025
- Melatonin Mitigates Sarcopenic Obesity via Microbiota and Short‐Chain Fatty Acids: Evidence From Epidemiologic and In Vivo StudiesJournal of Cachexia, Sarcopenia and Muscle, 2025
- The microbiologist's guide to metaproteomicsiMeta, 2025
- The Next Generation Fecal Microbiota Transplantation: To Transplant Bacteria or ViromeAdvanced Science, 2023
- Effects of an Exercise Program on Cardiometabolic and Mental Health in Children With Overweight or ObesityJAMA Network Open, 2023
- Full-Length 16S rRNA Gene Analysis Using Long-Read Nanopore Sequencing for Rapid Identification of Bacteria from Clinical Specimens2023
- Therapeutic Effects of Butyrate on Pediatric ObesityJAMA Network Open, 2022
- Obesity and gut–microbiota–brain axis: A narrative reviewJournal of Clinical Laboratory Analysis, 2022
- Effects of Fecal Microbiome Transfer in Adolescents With ObesityJAMA Network Open, 2020
- Microbiome Sequencing Methods for Studying Human Diseases2018